
Sign up to save your podcasts
Or


In this third episode, I had the pleasure of interviewing Amelie Quilichini, CEO and cofounder of Kolibri Lab. Amélie founded Kolibri Lab while being at Entrepreneur First, a deeptech accelerator and investor. Prior to that she worked as a strategy consultant for 5 years. Kolibri Lab unlocks patient access to cell and gene therapies by reducing production costs up to 50 times and increasing yield up to 100 times. It was also interesting to discuss their current fundraising process. Amélie is in the process of raising 5 million euros.
By Ilan Levy-LambertIn this third episode, I had the pleasure of interviewing Amelie Quilichini, CEO and cofounder of Kolibri Lab. Amélie founded Kolibri Lab while being at Entrepreneur First, a deeptech accelerator and investor. Prior to that she worked as a strategy consultant for 5 years. Kolibri Lab unlocks patient access to cell and gene therapies by reducing production costs up to 50 times and increasing yield up to 100 times. It was also interesting to discuss their current fundraising process. Amélie is in the process of raising 5 million euros.